South Korean biotech firms are targeting the $26 billion biosimilar market opening up as patents expire on more than 10 blockbuster drugs in the United States this year. Biosimilars are copi...
South Korea accounted for 42.9% of all hair loss cosmetic patents filed worldwide over the past two decades, the highest share among major economies, according to government data released on...
The U.S. Department of Energy (DOE) has designated South Korea as a “Sensitive and Other Designated Country” (SCL), a list historically reserved for sanctioned nations or those deemed securi...
The University of Pennsylvania has instructed department heads to significantly cut graduate admissions, with one department reportedly planning to rescind offers for 10 of the 17 students i...
South Korea is reviewing whether to include COVID-19 vaccines in its National Immunization Program (NIP) as the virus continues to spread alongside seasonal flu. The move is aimed at bolster...
South Korea’s two leading biopharmaceutical companies, Samsung Biologics and Celltrion, unveiled ambitious plans to enter the antibody-drug conjugate (ADC) market at the J.P. Morgan Healthca...
The combination therapy of Leclaza (lazertinib), South Korea’s first domestically developed anti-cancer drug approved by the U.S. Food and Drug Administration (FDA), has demonstrated potenti...
The rise of large language models (LLMs), imitation learning, and other AI technologies is driving explosive growth in the AI robotics market. Over the past 10 years, LG Electronics has fil...
A year-long management dispute within the Hanmi Pharmaceutical Group family is nearing resolution. The conflict began in January when the group’s consolidation plan with OCI Group triggered ...
On Dec. 23, Science and ICT Minister Yoo Sang-im stressed the urgent need to prepare for the commercialization of quantum technologies during a press briefing near the Government Complex Sej...
